This content is machine translated Locally advanced or metastatic urothelial carcinoma Subgroup analyses of the JAVELIN Bladder 100 study – In the context of clinical practice. First-line chemotherapy followed by avelumab (BAVENCIO®)-maintenance therapy is the standard of care for patients with locally advanced or metastatic urothelial carcinoma who have not progressed on platinum-based chemotherapy, according to…
View Post 3 min This content is machine translated AI-assisted skin cancer detection Deep learning algorithm to accelerate dermatopathology assessment. AI-based algorithms have the potential to support dermatopathology diagnosis making in the future. Currently, many research efforts are underway in this regard. Among other things, a deep learning algorithm was…
View Post 3 min This content is machine translated From symptom to diagnosis dysphagia – cervical and intrathoracic lipoma Benign adipose-derived tumors from mature adipocytes are among the most common mesenchymal tumors, but are uncommon in cervical and intrathoracic soft tissues. Imaging reveals fat-equivalent density values in the smoothly…
View Post 3 min This content is machine translated Radiation Oncology Challenges and changes in practice The theme of the 2022 ASTRO Annual Meeting was “Artificial Intelligence and Emotional Intelligence: caring for the patient in a wireless world.” The central role of human interaction in patient…
View Post 3 min This content is machine translated New S3 Guideline Lung Cancer Improve prevention, diagnostics, therapy and aftercare Today, the treatment of lung cancer is much more differentiated and also more complicated than it was ten years ago. This is due not least to the great dynamism in…
View Post 7 min This content is machine translated Genitourinary cancers Effective therapy management up-to date “Shaping the future together” was the motto of this year’s urology congress. Because health care must evolve. It is not only colleagues in the field of urology who are in…
View Post 6 min This content is machine translated Tumor Medicine Cancer medicine between innovation and care Inspirations, ideas and visions for the future were the focus of this year’s DKK. About 10,000 visitors exchanged information on the interfaces of tumor medicine, rare cancers and new diagnostic…
View Post 5 min This content is machine translated Multiple Myeloma (MM) BLENREP payable by health insurer in heavily pretreated refractory MM. Belantamab mafodotin (BLENREP) is the first and only BCMA*-targeted antibody-drug conjugate to be approved in Switzerland in June 2022, and has been reimbursable since November 2022 for the treatment of…
View Post 4 min This content is machine translated Multiple Myeloma Antibody-drug conjugate now reimbursable in heavily pretreated refractory multiple myeloma A first-in-class BCMA-targeted antibody-drug conjugate for the treatment of multiple myeloma in heavily pretreated adult patients who experienced disease progression during their last therapy has been approved in Switzerland since…
View Post 1 min This content is machine translated Swiss Oncology in Motion Module Urothelial Carcinoma Oncology is constantly changing, with additional diagnostic procedures, new surgical methods and innovative therapeutic concepts being developed. For this reason, the treatment guidelines are also continuously revised. This also applies… CME-Test
View Post 5 min This content is machine translated Colorectal cancer screening What are the most important quality standards for colonoscopy? Colonoscopy is an important screening procedure to detect and remove adenomas and polyps that can potentially lead to colorectal cancer. For several years, a high adenoma detection rate has been…